Position in ABBV
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$36,531,333
+$4,631,641 QoQ
Shares Held
145,173
-1.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#436
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLIFFORD SWAN INVESTMENT COUNSEL LLC holds $170,286,954 across 10 Drug Manufacturers - General names. ABBV ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
207,571 | $52,716,806 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
145,173 | $36,531,333 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
293,833 | $16,930,657 | |
| 4 | NVO |
Novo Nordisk A S
|
318,484 | $15,268,122 | |
| 5 | AMGN |
Amgen Inc
|
36,058 | $13,057,322 | |
| 6 | PFE |
Pfizer Inc
|
458,641 | $11,044,075 | |
| 7 | MRK |
Merck & Co., Inc.
|
75,680 | $9,724,880 | |
| 8 | NVS |
Novartis AG
|
60,118 | $9,421,692 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,531,333 | 145,173 | Shares | Other | 2026-08-20 | |
| 2026-03-31 | $31,899,692 | 146,672 | Shares | Other | 2026-05-06 | |
| 2025-12-31 | $33,963,438 | 148,643 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $35,234,599 | 152,175 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $28,276,608 | 152,336 | Shares | Other | 2025-07-30 | |
| 2025-03-31 | $32,249,318 | 153,920 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $27,810,227 | 156,501 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $30,979,082 | 156,872 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,982,287 | 163,143 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $29,766,248 | 163,461 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $26,661,348 | 172,042 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $25,876,219 | 173,596 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $23,872,673 | 177,189 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $28,481,968 | 178,716 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $29,556,529 | 182,888 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $25,377,097 | 189,085 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $31,191,952 | 203,656 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $33,004,623 | 203,594 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $28,407,732 | 209,806 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $23,117,835 | 214,312 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $24,442,767 | 216,999 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $27,223,606 | 251,558 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $27,120,843 | 253,111 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $22,685,372 | 258,995 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $25,898,411 | 263,785 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $18,465,027 | 242,355 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||